Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

92.87

+5.07 (5.77%)

Mar 4, 2026, 3:45 PM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	521.31M	336.89M	186.37M	77.06M	19.14M
Pharmaceuticals Growth	54.74%	80.76%	141.85%	302.66%	-
Total	521.31M	336.89M	186.37M	77.06M	19.14M
Total Growth	54.74%	80.76%	141.85%	302.66%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	401.55M	274.17M	146.70M	67.92M	2.91M
United States Growth	46.46%	86.89%	115.99%	2231.62%	-
Rest of the World	119.77M	62.24M	32.18M	7.14M	225.00K
Rest of the World Growth	92.44%	93.43%	350.50%	3074.22%	-
Total	521.31M	336.41M	178.87M	75.06M	3.14M
Total Growth	54.96%	88.07%	138.30%	2292.03%	-

Source: S&P Global Market Intelligence.